Molecule of the Month. TREDAPTIVE (nicotinic acid/laropiprant): a new lipid-modifying therapy for the treatment of LDL-C, HDL-C and triglycerides.
Felts
Andrew S
AS
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6600, USA.
D000818:Animals; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D050171:Dyslipidemias / Q000188:drug therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007211:Indoles; C518174:MK-0524; D014280:Triglycerides; D009525:Niacin